<figure class="image"><img src="https://enlitenaiweb.blob.core.windows.net/media/uploads/digital_logo_75bd392e79.png"></figure> <a href="https://www.globenewswire.com/Tracker?data=Pc-R3LRVZug_qvoHQUCbJestA_eCD_gWF0TNnHlH_lygAvLcM1K0cKED3Bgiy2BagHKIaegTiL75kRwRkY55aQ==">EnlitenAI</a>, an <a href="https://www.globenewswire.com/Tracker?data=2aM6V8qwWvUyqPP4K62dbIHmrCtpku69HopwkniAc9ZVXZql1mg30XJ_t03zp5ranCDHvmDTOPNufxz56bJlugU6tX_ZLjoiTATTHEX4G2H58BWmJNBydybaGxslm6sbDCGTrTO_xKfpmlU3bc1XgQ==">Innosphere Ventures</a> graduate company, proudly announces its selection as a quarterfinalist in the prestigious <a href="https://www.globenewswire.com/Tracker?data=EobZiNXUtM3WtfWxTAuW8WFFNCqpZhGE7GNL_S-g6aZzcPsYITruMxCME_I4nmmoTAwTLuK1ATM0MpmJgZ4g-sIGOKz-u0NFRTbXuTiFqiJyjkvWABgQqV6U-NB_uefO">Digital Health Awards</a> presented by the Digital Health Hub Foundation. Out of an overwhelming 1,500 submissions, EnlitenAI has secured its spot due to its innovative focus on using AI to personalize seizure management.&nbsp;At the heart of EnlitenAI's innovation is the Neuroliten platform. As described by Dr. Himanshu Misra, Founder &amp; CEO of EnlitenAI, “Our Neuroliten platform aggregates neurological indicators from wearables and devices to create insights for personalized seizure treatment and drug titration.” &nbsp;This pioneering effort stands out, especially in the face of challenges highlighted by Dr. Vikram Rao, Chief of the Epilepsy Center at <a href="https://www.globenewswire.com/Tracker?data=jD-gEJ5LeuUsmVW4-aMIOAF7Y3hTQbA4wN1O9SEQKtMgttffnfepjNpZDmIRM5KQ5W8gvBld6t4YjCqb93UpmA==">UCSF</a>: “The unpredictable nature of seizures and the lack of patient-specific responses to medication make it difficult to build detailed treatment plans. EnlitenAI’s Neuroliten platform provides visibility of the progression of patients’ symptoms and generates valuable insights for timely intervention.”&nbsp;Similarly, Dr. Sean Pauzauskie, a Neurologist with <a href="https://www.globenewswire.com/Tracker?data=0HtGMUvqcf5S329mhftH7IHiZ0cFg0fwWF4Rw6aBJln18FAN-N5uOk-hvm-EibNiLsIktvmXDAWy2q14k1NRrw==">UCHealth</a>, emphasized the platform's real-world applications: “Our team at UCHealth was particularly interested to investigate how Neuroliten could be used to capture real-world evidence. We are encouraged by the data that has been captured and the potential of Neuroliten to help personalize clinical treatment of seizures for better health outcomes for our patients.”&nbsp;From an economic perspective, Dr. Michael Meyers, a notable figure from the insurance sector, pinpointed the platform's dual advantage: “Neuroliten helps neurologists not only deliver better health outcomes but also get reimbursed at higher rates for Insurance carriers, the reduction in hospitalizations and shortened titration cycles dramatically reduce their cost burden.”&nbsp;Beyond its technological achievements, EnlitenAI's growth has been spurred by its collaboration with industry accelerators. Dr. Misra recollected a significant milestone: "One of the turning points in the journey of EnlitenAI was its selection to <a href="https://www.globenewswire.com/Tracker?data=2aM6V8qwWvUyqPP4K62dbDCkQuf0o5jD39p1N9QWxdE5dmh6CqMW_o8iKviTvG0C4fVgHAewmDUJMLIkQdqlQdLZM6p_4NvZSRUXWYHciF67SuFV9G4Hs3vkNIEq3nYjGNXWq7niibpCoJte9nvFJg==">Innosphere Ventures’ Accelerator program</a> and the mentorship the company received."&nbsp;Additionally, Dr. Misra added, "At EnlitenAI, our strength lies in the diversity and expertise of our team, a unique blend of passionate technologists, renowned neurologists, and regulatory pathway experts who have cohesively built our Neuroliten platform. Under the operational guidance of Abhiroop Gandhi, our COO and former chief of compliance &amp; regulatory risk at Verily Lifesciences, and the technological leadership of Sreeman Nanduri, our CTO experienced in digital health platform integration, we are reshaping clinical operations and regulatory strategy. Our medical direction is steered by Dr. Paul Garcia, a distinguished epileptologist and Professor of Neurology from UCSF. Further enriching our capabilities is a neurologist advisory panel, featuring luminaries such as Drs. Paul Garcia and Vikram Rao from UCSF, Dr. JP Appendino from Alberta Children’s Hospital, Dr. Sean Pauzauskie from UCHealth in Colorado, Dr. Vaishnav Krishnan from the Baylor College of Medicine, and Dr. Masoom Desai from the University of New Mexico. This team has been instrumental not only in charting EnlitenAI’s functionality roadmap but also in designing groundbreaking clinical investigations."&nbsp;The accolades from the industry have been overwhelming. Mark Goldstein, Chairman of Digital Health Hub Foundation, praised the high caliber of entrants this year, stating, "We are so impressed by the pioneering work in digital health happening on a global scale. Congratulations to all of our quarterfinalists on their notable success.”With the finalists to be unveiled on September 22 and the grand finale set for October 9 in Las Vegas, EnlitenAI is poised for even greater recognition in the healthcare technology arena.&nbsp;About EnlitenAI:Originating from Silicon Valley, EnlitenAI is at the forefront of using AI/ML and remote patient monitoring to transform personalized seizure management.&nbsp;About the Digital Health Hub Foundation:Initiated in 2017 at UCSF, San Francisco, the foundation's mission is to champion global healthcare innovations. Their expansive 30,000-member community brings together startups, experts, and investors, culminating in an annual awards ceremony celebrating healthcare's finest technological strides.&nbsp;About Innosphere Ventures:Innosphere Ventures is a regional incubator program that accelerates the success of founders, researchers, entrepreneurs, and university researchers who are launching and scaling technology and science-based startups through accelerator programs, office and specialized wet laboratory facilities, and venture capital funds. Innosphere is a 501(c)(3) non-profit with a mission to grow the region's innovation ecosystem and to support the commercialization efforts of startup companies.

digital-logo.png

EnlitenAI Emerges as a Prominent Contender at the Digital Health Awards

<figure class="image"><img src="https://enlitenaiweb.blob.core.windows.net/media/uploads/QF_RS_HHDM_Enliten_Ai_1_4cf4bc9733.png"></figure> San Francisco, Sept 12, 2025 —&nbsp;EnlitenAI,&nbsp;is thrilled to announce its selection as a quarterfinalist for the prestigious 2025 Digital Health Hub Foundation: Digital Health Awards.&nbsp;EnlitenAI&nbsp;was chosen as a quarterfinalist for the&nbsp;Rising Star&nbsp;-&nbsp;Home Health Diagnostics &amp; Monitoring category.&nbsp;&nbsp;This recognition highlights the company's dedication to revolutionize the way neurological and. Neurobehavioral disorders are treated today. The Digital Health Hub Awards celebrate organizations that demonstrate excellence in leveraging digital advancements to enhance healthcare services and patient outcomes. As a quarterfinalist, EnlitenAI stands out for its commitment to&nbsp;deliver precision neurological and neurobehavioral care by transforming passive monitoring into proactive, personalized intervention – powered by a device-agnostic, context-aware AI platform.&nbsp;This recognition highlights EnlitenAI for its significant contributions to advancing Seizure management. The Digital Health Hub Foundation Awards honor organizations making strides in improving healthcare speed, efficiency and equity with their digital innovations. Being named a quarterfinalist reflects EnlitenAI’s commitment to driving meaningful change in the healthcare landscape.&nbsp;We are honored to be recognized as a quarterfinalist by the Digital Health Hub Foundation. This recognition affirms our mission to transform neurological care by moving beyond passive monitoring toward proactive, personalized intervention—delivering clarity and confidence for patients, caregivers, and clinicians alike."&nbsp;— Himanshu Misra, PhD, Founder &amp; CEO, EnlitenAI&nbsp;Out of a substantial pool of over 1,800 submissions, only the most promising 16 quarterfinalists per category, per track have advanced to this stage.&nbsp;“The 2025 Awards have once again raised the bar, drawing an unprecedented range of global submissions that highlight the rapid evolution of AI and impact of digital health. Congratulations to all of our quarterfinalists for pushing the boundaries of what’s possible and driving meaningful change in healthcare,”&nbsp;said Mark H. Goldstein, Chairman of the Digital Health Hub Foundation.&nbsp;Finalists will be announced October 4, 2025.&nbsp;About Digital Health Hub Foundation:&nbsp;Our mission is to help the world’s next best innovative healthcare companies scale and grow. Founded in 2017, on the campus of UCSF in San Francisco, our now 30,000 member community consists of thousands of early-to late-stage healthcare companies and highly qualified healthcare industry providers, payors, experts, mentors, investors, clinicians and researchers who participate in our annual awards ceremony where we bring togetherthe industry to honor and validate the best of the best and celebrate the technological advances in healthcare and the impact it has. About EnlitenAI Inc.:&nbsp;EnlitenAI is a digital health startup advancing precision care in neurology and mental health. Its device-agnostic AI platform,&nbsp;Neuroliten, integrates multimodal data from FDA-cleared devices to generate personalized insights that improve outcomes, optimize titration of drugs and devices, and reduce healthcare costs. While its initial focus is epilepsy and seizure management, EnlitenAI’s scalable technology is designed to support a wide range of neurological and neurobehavioral disorders.

San Francisco, Sept 12, 2025 — EnlitenAI, is thrilled to announce its selection as a quarterfinalist for the prestigious 2025 Digital Health Hub Foundation: Digital Health Awards.

Untitled_design__2_-removebg-preview.png

EnlitenAI Recognized as Quarterfinalist for the 2025 Digital Health Hub Foundation: Digital Health Awards

<h3>Unlocking Innovation Nationwide: A Testimonial from EnlitenAI (<a href="https://www.linkedin.com/in/himanshumisraphd?trk=public_post-text" target="_blank" rel="noopener noreferrer">Dr. Himanshu Misra</a> ), Innosphere Life Sciences Graduate Company</h3>&nbsp;At EnlitenAI, our journey began with a deeply personal mission: to revolutionize seizure management after the heartbreaking loss of our beloved son to epilepsy. Founded in February 2021, our vision was clear but our path forward was less defined. That's when we found Innosphere Ventures.&nbsp;Navigating the complex landscape of digital healthcare required more than just a great idea—it demanded guidance, mentorship, and a supportive ecosystem. In August 2021, we embarked on a search for an accelerator program that could match our global ambitions and diverse team. After careful consideration, we chose Innosphere, and it's a decision we've never regretted.&nbsp;Here's why:&nbsp;&nbsp;Streamlined Process: From the outset, Innosphere stood out with its well-structured screening questionnaire, which immediately resonated with our needs.&nbsp;Speedy Response: Unlike other programs with lengthy waiting periods, Innosphere impressed us with their quick turnaround time. Within days, we were engaged in a meaningful dialogue with their Mentor Leadership team.&nbsp;Professional Engagement: The interview session with Mentor Leaders like Ben Walker was a pivotal moment. It wasn't just about being shortlisted; it was about receiving invaluable insights and suggestions to enhance our market positioning.&nbsp;Comprehensive Program: Innosphere's accelerator program was a revelation. Each week brought focused discussions on critical healthcare themes, coupled with personalized mentorship sessions tailored to our needs.Expansive Ecosystem: Through Innosphere, we gained access to a vast network of industry experts—from regulatory advisors to neurologists within the UCHealth system—who provided invaluable guidance and support.&nbsp;Strategic Partnerships: Through Innosphere's connections, we forged strategic relationships with UCHealth and successfully applied for state grants, opening doors to further opportunities.Clinical Validation: Perhaps most importantly, Innosphere facilitated a proof of concept clinical study, validating our solution and propelling us forward with confidence.&nbsp;But beyond the program itself, what truly sets Innosphere apart is the enduring relationships it fosters. Even after graduating almost two years ago, we continue to benefit from our connection with Innosphere, whether it's through ongoing support or assistance in crucial interviews and staffing.&nbsp;As we continue our journey of growth and impact, we are proud to carry the badge of an Innosphere alumni. EnlitenAI's success is inextricably linked with the support and guidance we received from Innosphere, and we look forward to the continued partnership as we strive to make a difference in healthcare.&nbsp; &nbsp;Do you want to be a part of our 2024 Life Sciences Program? Visit <a href="https://innosphereventures.org/lifesciences-program/" target="_blank" rel="noopener noreferrer">Innosphere Ventures</a>&nbsp;<figure class="image image-style-align-center"><img src="https://enlitenaiweb.blob.core.windows.net/media/uploads/1707778354059_a1f1869a47.jfif" alt="Ben Walker &amp; Dr. Himanshu Misra"></figure>&nbsp;(Pictured <a href="https://www.linkedin.com/in/ben-walker-61b58a?trk=public_post-text" target="_blank" rel="noopener noreferrer">Ben Walker</a> &amp; <a href="https://www.linkedin.com/in/himanshumisraphd?trk=public_post-text" target="_blank" rel="noopener noreferrer">Dr. Himanshu Misra</a> )&nbsp;

At EnlitenAI, our journey began with a deeply personal mission: to revolutionize seizure management after the heartbreaking loss of our beloved son to epilepsy.

1707778354059.jfif

Unlocking Innovation Nationwide

&nbsp;Photo and video: Available for&nbsp;<a href="https://www.dropbox.com/scl/fo/e7btmnnyrl3ouerovwfv6/h?dl=0&amp;rlkey=bn9d941ney71fnel9s0cy4lii">download here</a>. &nbsp;&nbsp;&nbsp;Contact info:Kelly TracerMedia Relations Manager, UCHealth Northern Colorado(970) 302-3290&nbsp;Betty MaisenbachMarketing Director, Innosphere Ventures(970) 221-1301&nbsp;&nbsp;UCHealth is partnering with EnlitenAI&nbsp;to monitor patients with drug-resistant epilepsy at home&nbsp;&nbsp;FORT COLLINS, Colo. (Oct. 18, 2022)&nbsp;–&nbsp;<a href="https://www.uchealth.org/">UCHealth</a> and&nbsp;<a href="https://enlitenai.com/">EnlitenAI</a> have been awarded an Advanced Industries grant from the State of Colorado to study the applicability of a cloud platform for personalized management of seizures in epileptic patients, especially those with drug-resistant epilepsy.&nbsp;&nbsp;A team of researchers and clinicians at UCHealth will lead efforts for the proof-of-concept study. The study will evaluate how the seamless accessibility of data from EnlitenAI’s cloud-based platform can be used in conjunction with its artificial intelligence engine to enable neurologists to create patient-specific seizure management plans for timely intervention.&nbsp;Many of these patients have a history of unpredictable seizures despite being on multiple anti-seizure medications. Effective management of seizures requires more frequent monitoring of the progression of each patient’s neurological condition and a better visibility of how each patient responds to the specific combination of medications, according to Dr. Gary Luckasen, UCHealth’s medical director of research in northern Colorado.&nbsp;&nbsp;“I am intrigued by the ability to create patient-specific treatment plans using data-driven guidance for drug titration,” said Dr. Sean Pauzauskie, a neurologist at UCHealth Poudre Valley Hospital in Fort Collins. “To date, drug titration efforts have primarily relied on a trial-and-error-based approach, which can take quite a long time. The sooner we can get the patient on the correct medication, the better it will be for the patient and their caregivers. We hope this observational study will help us get to that perfect match sooner.”&nbsp;The EnlitenAI platform, called Neuroliten, monitors and records patients’ vital signs and other neurological indicators through the use of wearables, such as wrist devices and EEG headsets. Caregivers also provide valuable information about the patients’ condition, observed side effects and all details associated with seizure events. Neuroliten’s AI engine generates valuable insights from the history of all seizure events using the data collected from devices and caregivers. Through this technology, physicians will get valuable information about the seizures, any likely triggers or side effects, which can help build patient-specific treatment plans.&nbsp;&nbsp;“This partnership will enable UCHealth to gather clinical evidence from their patients in real-world scenarios,” said Dr. Himanshu Misra, CEO and co-founder of EnlitenAI. “We intend to use this information to further refine the functionalities of Neuroliten, allowing for broad application of this program by neurologists when treating patients with epilepsy.”&nbsp;&nbsp;EnlitenAI is a digital health startup that is in a cohort of the&nbsp;<a href="https://innosphereventures.org/">Innosphere Ventures</a>’ nonprofit accelerator program aimed at using science and technology to improve health care delivery.&nbsp;“We are excited to introduce Neuroliten to help patients who are struggling with epilepsy,” said Mike Freeman, CEO of Innosphere Ventures. “Innovative technologies such as this allows physicians to more rapidly treat chronic conditions is a big part of why we exist. We are grateful to the State of Colorado for the grant.”&nbsp;&nbsp;Public-private partnerships are often at the forefront of cutting edge advances in technology, and proof-of-concept grants are designed to help Colorado research institutions and their private partners speed up applied research, according to Rama Haris, senior manager of Advanced Industries at the Colorado Office of Economic Development and International Trade. “The project being undertaken by UCHealth and EnlitenAI has the potential to transform the way seizures and drug-resistant epilepsy are managed. We're excited to see what they accomplish with this funding and how their work helps transform the healthtech industry as a whole.”&nbsp;&nbsp;&nbsp;<figure class="image"><img src="https://enlitenaiweb.blob.core.windows.net/media/uploads/news_announcements_3e96ff6691.png" alt="statistic"></figure>&nbsp;&nbsp;About UCHealthUCHealth is an innovative, nonprofit health system that delivers the highest quality medical care with an excellent patient experience. UCHealth includes 29,000 employees, 12 acute-care hospitals and hundreds of physicians across Colorado, southern Wyoming and western Nebraska. With University of Colorado Hospital on the CU Anschutz Medical Campus as its academic anchor and the only adult academic medical center in the region, UCHealth is dedicated to providing unmatched patient care in the Rocky Mountain West. Offering more than 150 clinic locations, UCHealth provides extensive community benefits and pushes the boundaries of medicine through advanced treatments and clinical trials, improving health through innovation.&nbsp;About EnlitenAIEnlitenAI is a SaaS Product startup that has built a Connected Platform (Neuroliten) with context-rich data to provide AI-driven valuable insights for effective management &amp; personalized treatment of Neurological conditions (immediate focus on Epilepsy/Seizures). Our connected platform enables accessibility of episode-specific information and wearables-based vital parameters monitoring by the minute.About Innosphere Ventures Innosphere’s nonprofit accelerator program has a solid mission to grow the region’s entrepreneurship ecosystem by supporting the success of science and technology companies with an exclusive commercialization program for high-tech startups and specialized laboratory facilities.&nbsp;&nbsp;

UCHealth is partnering with EnlitenAI  to monitor patients with drug-resistant epilepsy at home 

news_announcements.png

UCHealth is partnering with EnlitenAI

EnlitenAI is a promising early-stage startup based in Tracy, California, that is building an AI-driven platform for better management and treatment of neurological conditions. EnlitenAI’s flagship product, NeuroLiten, is a cloud-based SaaS subscription platform designed to address the specific needs of patients suffering from seizures and epilepsy, and eventually, other neurological conditions.With its cutting-edge technology, EnlitenAI aims to revolutionize the way neurological care is delivered, personalized, and monitored. The company’s vision is to create a connected platform that leverages the power of AI, data analytics, wearables, and IoT devices to provide patients with personalized healthcare that is tailored to their unique needs.&nbsp;<h2 style="margin-left:0px;">Epilepsy as the Immediate Focus</h2>EnlitenAI’s NeuroLiten platform focuses on epilepsy and seizures as a starting point to build appropriate functionality and features. Epilepsy offers specificity that is required to create a platform with the right algorithms and data. The company is currently building a comprehensive library of data and algorithms to address the needs of epilepsy patients, which will be further extended to other neurological conditions.&nbsp;<h2 style="margin-left:0px;">Scalable and Extendable Platform</h2>EnlitenAI’s NeuroLiten platform is both scalable and extendable, designed as a connected platform for personalized healthcare for neurological conditions. The platform leverages AI, data analytics, wearables, and IoT devices to provide a comprehensive healthcare solution. EnlitenAI’s platform is mobile and web-enabled, ensuring that patients have access to their healthcare information wherever they go.&nbsp;<h2 style="margin-left:0px;">Monitoring Vital Parameters with Wearables</h2>EnlitenAI’s NeuroLiten platform enables patients to monitor their vital parameters using wearables, which is then integrated with AI and data analytics to provide personalized healthcare. The platform uses context-rich data to provide patients with insights into their health, including how their lifestyle and environment affect their condition. NeuroLiten’s AI-driven platform enables physicians to make data-driven decisions, enabling personalized treatment for patients.&nbsp;<blockquote><a href="https://usventure.news/startup-showcase-april-eldridge-consulting-llc-navigating-the-complexities-of-business/">Read more from US Venture News&nbsp; Startup Showcase: April Eldridge Consulting LLC - Navigating the Complexities of Business</a></blockquote>&nbsp;<h2 style="margin-left:0px;">The Future of Neurological Care</h2>EnlitenAI’s vision is to build an end-to-end platform that creates a novel healthcare delivery system by monitoring patient vital parameters using wearables and leveraging AI/Analytics on context-rich data for personalized healthcare. The company aims to expand its business into adjacent market segments for autism, ADD, behavioral and sleep disorders, Parkinson’s Disease, Alzheimer’s, and other neurological conditions.&nbsp;<h2 style="margin-left:0px;">Conclusion</h2>EnlitenAI’s NeuroLiten platform is the future of neurological care, leveraging AI, data analytics, wearables, and IoT devices to provide personalized healthcare that is tailored to each patient’s unique needs. The platform is scalable and extendable, enabling EnlitenAI to expand its business into adjacent market segments, providing a comprehensive healthcare solution for patients suffering from neurological conditions.&nbsp;Website: <a href="https://www.enlitenai.com/">https://www.enlitenai.com</a>Twitter: <a href="https://twitter.com/enlitenai">https://twitter.com/enlitenai</a>Facebook: <a href="https://www.facebook.com/enlitenai">https://www.facebook.com/enlitenai</a>LinkedIn: <a href="https://www.linkedin.com/company/enlitenai/">https://www.linkedin.com/company/enlitenai/</a>

EnlitenAI is a promising early-stage startup based in Tracy, California, that is building an AI-driven platform for better management and treatment of neurological conditions

startup_showcase.jpg

Startup Showcase: EnlitenAI – Revolutionizing Neurological Care with AI-Driven Platform for Seizures and Epilepsy Management

<figure class="image"><img src="https://enlitenaiweb.blob.core.windows.net/media/uploads/1757046087119_007f7cae05.jpg"></figure> I had the pleasure of attending the Pitch Elk Grove event tonight and what an amazing event! We heard 9 startup pitches that were vying for top prizes and 7 elevator pitches that were seizing an opportunity for air time. The innovation, passion, and excitement in the room was palpable. Well done <a href="https://www.linkedin.com/company/investelkgrove/">Invest Elk Grove - Elk Grove, CA's Office of Economic Development</a> for bringing such talent to our community and a very successful night.&nbsp; Congratulations to the winners tonight and all the brave pitchers who came out, looking forward to next year’s event!&nbsp; Thank you to <a href="https://www.linkedin.com/search/results/all/?keywords=%23kaiserpermanente&amp;origin=HASH_TAG_FROM_FEED">#kaiserpermanente</a> for investing in and supporting the community we serve.

I had the pleasure of attending the Pitch Elk Grove event tonight and what an amazing event!

1757046087119.jpg

EnlitenAI won the 2nd Prize on Sept 4 at the Pitch Elk Grove competition.

<h3 style="margin-left:0px;">The Moment Inspiration Struck</h3>&nbsp;Can you walk us through the moment you decided to turn your personal story into a startup?&nbsp;Himanshu: In 2021, I lost my son to epilepsy—a life-changing moment that transformed grief into purpose. I made a personal commitment to create solutions that could ease the burden for millions of families facing intractable seizures and, ultimately, save lives. Drawing on my professional background in computational sciences and numerical methods, I realized I could bring a fresh lens to a space where technology had lagged behind patient need.&nbsp;That’s how EnlitenAI was born—at the intersection of lived experience and deep technical expertise. Unlike many digital health tools that focus narrowly on detection, our platform is designed around the daily realities of patients and caregivers, helping personalize treatment and preempt crises. EnlitenAI is more than a company: it’s a mission-driven effort fueled by love, science, and a vision of truly patient-centered neurology care. EnlitenAI is truly a story of love and passion!<h3 style="margin-left:0px;">&nbsp;</h3><h3 style="margin-left:0px;">From Idea to Launch</h3>&nbsp;What were some of the first steps you took to move from concept to actually launching EnlitenAI?&nbsp;Himanshu: While the idea for EnlitenAI was born out of lived experience, I knew that a strong concept wasn’t enough—we needed validation within real clinical workflows. The first step was building a leadership team and an advisory council of experts in areas where I had limited knowledge, including FDA regulatory pathways, EMR integration, reimbursement, and clinical decision support.&nbsp;I also immersed myself in accelerator programs such as Innosphere, LifeX/Jumpstart, the Epilepsy Foundation, and IIT Startups. These platforms gave us access to mentors, clinicians, and investors who helped us sharpen our product roadmap, design clinically relevant studies, and prioritize features. Those early steps laid the foundation for translating a deeply personal mission into a credible, clinically aligned company.<h3 style="margin-left:0px;">&nbsp;</h3><h3 style="margin-left:0px;">Overcoming the Hardest Moments</h3>&nbsp;Founding a company rooted in personal loss must have been both motivating and difficult. What helped you push through the hardest moments?&nbsp;Himanshu: Founding EnlitenAI was born out of heartbreak, but also out of a deep conviction. Losing our son was devastating, yet it gave me an unwavering commitment to confront the challenges of epilepsy head-on. My family’s support was invaluable, but what kept me going was the mission itself—the belief that no family should go through what we did.&nbsp;Having lived through the unpredictability of seizures and the frustration of trial-and-error treatments, I knew exactly which gaps had to be addressed. That clarity, combined with a team that shares the same conviction, has helped me push through the hardest moments and stay focused on building a solution that can change lives.<h3 style="margin-left:0px;">&nbsp;</h3><h3 style="margin-left:0px;">Building Trust with Stakeholders</h3>&nbsp;Were there any early challenges in building trust with clinicians, patients, or investors, and how did you overcome them?&nbsp;Himanshu: Our earliest validation came from patients and caregivers, who immediately recognized the value of our approach and helped refine the user experience. Clinicians were also quick to support us, and within months leading neurologists from UCSF, UCHealth, Baylor, CEPN, UC Davis, and the University of New Mexico joined our advisory network.&nbsp;With investors, the challenge was less skepticism and more unfamiliarity with the epilepsy market, which has long been underfunded. That is why we focused on strong clinical collaborations and generating real-world data. The momentum we have built with patients and top neurologists puts us in a strong position to close this gap and highlight one of the most overlooked opportunities in neurology and digital health.<h3 style="margin-left:0px;">&nbsp;</h3><h3 style="margin-left:0px;">The Role of the Startup Community</h3>&nbsp;How has the Bay Area or broader startup community supported you on this journey?&nbsp;Himanshu: The Bay Area and Sacramento startup ecosystems have been the launchpad for EnlitenAI’s growth. Through the IIT Startups Accelerator, we accessed seasoned angels and entrepreneurs who sharpened our fundraising and go-to-market strategy. In Northern California, AngelCon, Growth Factory, and other investor networks have expanded our reach and opened critical doors.&nbsp;We were honored to win 2nd Prize at Pitch Elk Grove, hosted by the City of Elk Grove and organized by StartupSac, marking a milestone that aligns with our strategy to launch EnlitenAI’s first commercial product in Sacramento. This region is uniquely suited as our proving ground—combining a strong clinical ecosystem with community-driven innovation.&nbsp;Clinically, we are already working with UC Davis and CEPN (Rocklin), while also engaging with Sutter Health, Dignity Health, and Kaiser. The support we’ve received here is more than local—it is helping us validate and refine our model in a real-world healthcare setting. This positions Sacramento and the Bay Area as the springboard for scaling EnlitenAI’s impact nationwide.<h3 style="margin-left:0px;">&nbsp;</h3><h3 style="margin-left:0px;">The Value of Mentorship and Advisors</h3>&nbsp;Have mentors, advisors, or programs played an important role in helping you grow EnlitenAI?&nbsp;Himanshu: Absolutely. Building a healthcare company in neurology, especially epilepsy, requires a cross-functional network of advisors and mentors, and EnlitenAI has been fortunate to draw on some of the very best.&nbsp;Our Neurologist Advisory team has been central in defining product features, ensuring integration into clinical workflows, and guiding clinical studies for regulatory and payer adoption. On the business and regulatory side, we have relied on QNova Life Sciences, the Epilepsy Foundation, Danny Did Foundation, Innosphere Ventures, and AngelCon to sharpen our strategy and accelerate product-market fit.&nbsp;Mentorship from accelerator programs such as Innosphere, LifeX/Jumpstart, and IIT Startups refined our value proposition and strengthened our business model, while the Epilepsy Foundation’s Accelerator and Danny Did Foundation gave us a platform to build device partnerships. Our induction into the Epilepsy Foundation’s dtRRE panel also provided unparalleled visibility in reimbursement and commercialization.&nbsp;This ecosystem of mentors and advisors remains one of our strongest assets in shaping both clinical impact and commercial success.<h3 style="margin-left:0px;">&nbsp;</h3><h3 style="margin-left:0px;">Evolution of the Vision</h3>&nbsp;How has your vision for EnlitenAI evolved since the beginning, and what excites you most about where it is headed?&nbsp;Himanshu: Our vision began with a focus on epilepsy and seizure management, rooted in the daily challenges patients and caregivers face. Over time, we realized our approach of combining device-agnostic telemetry with AI decision support can extend to other neurobehavioral disorders, including autism, depression, anxiety, and PTSD.&nbsp;Conversations with UC Davis Neurology have shown the value of integrating mental health monitoring alongside seizure detection, creating a more holistic view of patient well-being. EnlitenAI is built to be scalable and flexible, addressing conditions where symptoms are episodic and treatment decisions are subjective.&nbsp;What excites me most is the opportunity to create patient-centered, data-driven pathways that improve outcomes, reduce hospitalizations, and provide actionable insights across a wide range of neurological and neurobehavioral&nbsp;&nbsp;conditions.<h3 style="margin-left:0px;">&nbsp;</h3><h3 style="margin-left:0px;">Advice for Mission-Driven Founders</h3>&nbsp;What advice would you share with other founders who want to transform a deeply personal experience into a mission-driven startup?&nbsp;Himanshu: My advice to mission-driven founders is to combine passion with discipline. Personal experience drives purpose, but building a scalable business requires expert guidance and attention to regulatory, clinical, and commercial realities. Stay close to the problem, but balance empathy with rigorous execution—this is how you create both meaningful impact and a viable, investable company.&nbsp;Interested in more Startup Stories? <a href="https://startupsac.com/category/sacramento-startup-profile/">Check them out here</a>.

EnlitenAI was born out of personal tragedy and a bold vision for patient-centered neurology care. 

EnlitenAI.png

EnlitenAI: Turning Loss Into Purpose

Stonehaven.webp

Financial Services and Investment Brokerage

mvmt_ventures.webp

Financial Services

emotiv.webp

Scalable and easy to use EEG technology for neuroscience, neuromarketing, cognitive performance and BCI

Picture10.png

EpiWatch

Picture9.png

Epitel

strike_graph.webp

SOC2 & regulatory Compliance and Consulting

briskinfosec.webp

Cybersecurity Solutions and Consulting

Button

Contact Us

Always looking out for you

thumbnail_Pattern_1_1_42ea9374fa.webp

Pattern_1_1_42ea9374fa.webp

thumbnail_Pattern_2_d53b6696a6 (1).webp

Pattern_2_d53b6696a6 (1).webp

176x86.webp

ucsf.webp

Picture6.png

Picture7.png

Picture8.png

innosphere_ventures.webp

Picture2.png

Picture3.png

Picture4.jpg

Picture5.png

plug_and_play.webp

aurelia_ven.webp

peachscore.webp

thumbnail_Pattern-2-_2_ (1).webp

Pattern-2-_2_ (1).webp

Ecosystem Partners

Mentorship and Strategic Business Advisors

Accelerator Ecosystem

Portals

Neurology Center Affiliations

thumbnail_Frame 11 (2).webp

Frame 11 (2).webp

Our Partners

nvidia.webp

Computer Hardware Manufacturing

amazon.webp

IT Services and IT Consulting

wilson_sonsini.webp

polsinelli.webp

vigorant.webp

Vigorant

Picture1.png

Provides regulatory and clinical services to pharmaceutical and medical device companies

Enliten News & Announcements